JC Virus (JCV) Molecular Detection, Quantitative, CSF
Synonyms |
|
||||||||
Cerner Name |
|||||||||
Clinical Info |
Quantitative JCV DNA PCR can be used to detect JCV in CSF in the setting of CNS disease, and blood and urine in the setting of renal dysfunction. Quantitative DNA PCR can be used to track the course of infection as well as monitor response to treatment. |
||||||||
Specimen Sources |
Lumbar Puncture |
||||||||
Specimen Types |
Cerebrospinal Fluid |
||||||||
Specimen Volume |
|||||||||
Container |
CSF Tube |
||||||||
Collection Instructions |
Container/Tube: Sterile screw cap vial Specimen Volume: 2 mL CSF ( 0.5 mL min) |
||||||||
Transport Instructions |
Frozen |
||||||||
Specimen Stability |
|||||||||
Methodology |
Real-Time Polymerase Chain Reaction (PCR) |
||||||||
Days Performed |
Monday through Saturday |
||||||||
Performing Laboratory |
Viracor Eurofins Clinical Diagnostics |
||||||||
CPT |
87799 |
||||||||
PDM |
5905860 |
||||||||
Only Orderable at Locations: |
Orderable Everywhere |
||||||||
Results |
|
||||||||
Result Interpretation
None detected
Assay Range: 72
copies/mL to 1.00E+08 copies/mL The limit of
quantitation (LOQ) is 72 copies/mL. JC virus DNA detected below the
LOQ will be reported as Detected:<72 copies/mL. This test was
developed and its performance characteristics determined by
Viracor Eurofins. It has not been cleared or approved by the U.S. Food
and Drug Administration. Results should be used in conjunction with
clinical findings, and should not form the sole basis for a
diagnosis or treatment decision. |
|||||||||
Forms |
|